MetLife Statistics
Total Valuation
MetLife has a market cap or net worth of $55.30 billion. The enterprise value is $82.11 billion.
Important Dates
The next estimated earnings date is Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | May 12, 2026 |
Share Statistics
MetLife has 643.44 million shares outstanding. The number of shares has decreased by -5.03% in one year.
| Current Share Class | 643.44M |
| Shares Outstanding | 643.44M |
| Shares Change (YoY) | -5.03% |
| Shares Change (QoQ) | -0.98% |
| Owned by Insiders (%) | 0.22% |
| Owned by Institutions (%) | 78.15% |
| Float | 537.50M |
Valuation Ratios
The trailing PE ratio is 16.66 and the forward PE ratio is 8.61. MetLife's PEG ratio is 0.76.
| PE Ratio | 16.66 |
| Forward PE | 8.61 |
| PS Ratio | 0.71 |
| Forward PS | 0.68 |
| PB Ratio | 2.03 |
| P/TBV Ratio | 3.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 3.56 |
| PEG Ratio | 0.76 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 23.91 |
| EV / Sales | 1.06 |
| EV / EBITDA | 13.82 |
| EV / EBIT | 15.82 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.09, with a Debt / Equity ratio of 1.78.
| Current Ratio | 2.09 |
| Quick Ratio | 1.75 |
| Debt / Equity | 1.78 |
| Debt / EBITDA | 8.33 |
| Debt / FCF | n/a |
| Interest Coverage | 4.86 |
Financial Efficiency
Return on equity (ROE) is 13.01% and return on invested capital (ROIC) is 4.54%.
| Return on Equity (ROE) | 13.01% |
| Return on Assets (ROA) | 0.45% |
| Return on Invested Capital (ROIC) | 4.54% |
| Return on Capital Employed (ROCE) | 0.74% |
| Weighted Average Cost of Capital (WACC) | 5.28% |
| Revenue Per Employee | $1.69M |
| Profits Per Employee | $74,652 |
| Employee Count | 46,000 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MetLife has paid $1.20 billion in taxes.
| Income Tax | 1.20B |
| Effective Tax Rate | 24.91% |
Stock Price Statistics
The stock price has increased by +8.65% in the last 52 weeks. The beta is 0.78, so MetLife's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | +8.65% |
| 50-Day Moving Average | 81.87 |
| 200-Day Moving Average | 78.33 |
| Relative Strength Index (RSI) | 55.38 |
| Average Volume (20 Days) | 4,046,306 |
Short Selling Information
The latest short interest is 15.88 million, so 2.47% of the outstanding shares have been sold short.
| Short Interest | 15.88M |
| Short Previous Month | 12.11M |
| Short % of Shares Out | 2.47% |
| Short % of Float | 2.95% |
| Short Ratio (days to cover) | 4.47 |
Income Statement
In the last 12 months, MetLife had revenue of $77.58 billion and earned $3.43 billion in profits. Earnings per share was $5.16.
| Revenue | 77.58B |
| Gross Profit | 18.43B |
| Operating Income | 5.19B |
| Pretax Income | 4.81B |
| Net Income | 3.43B |
| EBITDA | 5.94B |
| EBIT | 5.19B |
| Earnings Per Share (EPS) | $5.16 |
Full Income StatementBalance Sheet
The company has $27.64 billion in cash and $49.49 billion in debt, giving a net cash position of -$26.80 billion or -$41.66 per share.
| Cash & Cash Equivalents | 27.64B |
| Total Debt | 49.49B |
| Net Cash | -26.80B |
| Net Cash Per Share | -$41.66 |
| Equity (Book Value) | 27.80B |
| Book Value Per Share | 42.30 |
| Working Capital | 49.32B |
Full Balance SheetCash Flow
| Operating Cash Flow | 15.52B |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 487.00M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 23.75%, with operating and profit margins of 6.69% and 4.66%.
| Gross Margin | 23.75% |
| Operating Margin | 6.69% |
| Pretax Margin | 6.20% |
| Profit Margin | 4.66% |
| EBITDA Margin | 7.66% |
| EBIT Margin | 6.69% |
| FCF Margin | n/a |